24-Mar-2020 | Facts and Factors
The global Diabetes Disposable Insulin Pen market in 2019 was approximately USD 9.5 billion. The market is expected to grow at a CAGR of 5.2% and is anticipated to reach around USD 16.8 billion by 2026.
Insulin is a vital component to control type 1 and type 2 diabetes. Insulin is usually used required the treatment of type 2 diabetes. New innovations are disposable insulin styles that were introduced some 20 years ago. Two forms of disposable insulin pens, namely reusable and disposable, are available. The pen used by a patient depends entirely on the type of diabetes that he or she has and the number of insulin units needed per shot. The size and shape of the needles used in disposable insulin styles vary. As these are mature markets, the markets for insulin pens in Europe and Japan are growing at a moderate rate. This has also resulted in an increase in the elderly population and an increase in the number of diabetic patients in these regions.
Browse the full “Diabetes Disposable Insulin Pen Market By Type (Type 1 Diabetes and Type 2 Diabetes) and By Distribution Channel (Hospitals, Clinics, Chemists, and Others): Global Industry Outlook, Market Size, Business Intelligence, Consumer Preferences, Statistical Surveys, Comprehensive Analysis, Historical Developments, Current Trends, and Forecasts, 2020–2026" https://www.fnfresearch.com/diabetes-disposable-insulin-pen-market-by-type-type-903
Some countries in the market of insulin pen devices are less well-pervaded such as India, China, and Brazil. These markets have enormous potential as they consist of a large aging population and diabetic patients. As a result, manufacturing companies are now focusing on the Asian Insulin Pen market.
Growth in the global market for disposable insulin pens is owed to a number of factors, including rising diabetes, high adoption rates, ergonomic design, and increased consumer popularity. In addition, the increasing demand for human insulin analogs, increased government support and technological advances in insulin pens are some of the other key factors driving the global market for disposable insulin pens. In addition, the R&D in the insulin industry is also projected to boost the market for insulin pens. However, the development of the market for insulin penises is limited by safety issues relating to the use of pens and strict new product development regulations.
By type, record population in the world suffering from type 1 diabetes in 2019 owing to the rise in the elderly population and the change in the eating habit amongst the population. Based on the distribution channel, the chemist segment dominated the global market in 2019 and accounted for approximately 27% of shares worldwide. This segment is anticipated to boost throughout the forecast period owing to its ease of access and negotiable prices.
On the basis of region, the North American region held the largest market share in 2019 and accounted for 34% of global shares. The increasing number of diabetic cases combined with the convenience of using insulin pens fueled the growth of the market in the North American Region.
Report Scope
Report Attribute |
Details |
Market Size in 2019 |
USD 9.5 Billion |
Projected Market Size in 2026 |
USD 16.8 Billion |
CAGR Growth Rate |
5.2% CAGR |
Base Year |
2020 |
Forecast Years |
2020-2026 |
Key Market Players |
Health Care Center, P.B Pharmaceuticals, INJEX, Owen Mumford, Ltd., Nipro Medical Corporation, Novo Nordisk A/S, Berlin-Chemie Ag, Companion Medical, Pendiq Gmbh, Eli Lilly And Company, Emperra GmbH E-Health Technologies, Ypsomed Ag, Biocon, Sanofi, and others. |
Key Segment |
By Type, By Distribution Channel, By Region |
Major Regions Covered |
North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa |
Purchase Options |
Request customized purchase options to meet your research needs. Explore purchase options |
Some of the essential players operating in the Diabetes Disposable Insulin market, but not restricted to include Health Care Center, P.B Pharmaceuticals, INJEX, Owen Mumford, Ltd., Nipro Medical Corporation, Novo Nordisk A/S, Berlin-Chemie Ag, Companion Medical, Pendiq Gmbh, Eli Lilly And Company, Emperra GmbH E-Health Technologies, Ypsomed Ag, Biocon, Sanofi, and others.
This report segments the Diabetes Disposable Insulin Pen market as follows:
Global Diabetes Disposable Insulin Pen Market: By Type Segmentation Analysis
- Type 1 Diabetes
- Type 2 Diabetes
Global Diabetes Disposable Insulin Pen Market: By Distribution Channel Segmentation Analysis
- Hospitals
- Clinics
- Chemists
- Others
Global Diabetes Disposable Insulin Pen Market: Regional Segmentation Analysis
- North America
- Europe
- Germany
- The UK
- France
- Spain
- Italy
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Southeast Asia
- Rest of Asia Pacific
- Latin America
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa
- GCC
- South Africa
- Rest of Middle East & Africa
About Us:
Facts & Factors is a leading market research organization offering industry expertise and scrupulous consulting services to clients for their business development. The reports and services offered by Facts and Factors are used by prestigious academic institutions, start-ups, and companies globally to measure and understand the changing international and regional business backgrounds. Our client’s/customer’s conviction on our solutions and services has pushed us in delivering always the best. Our advanced research solutions have helped them in appropriate decision-making and guidance for strategies to expand their business.
Contact Us:
Facts & Factors
A - 2108, Sargam,
Nanded City,
Sinhagad Road,
Pune 411041, India
USA: +1-347-989-3985
Email: [email protected]
Web: https://www.fnfresearch.com
